ChengDa Pharmaceuticals Co. Ltd. (301201) — Capital Reinvestment Ratio
ChengDa Pharmaceuticals Co. Ltd. (301201) has a Capital Reinvestment Ratio of 10.00x as of December 2024, meaning it reinvests 10% of its operating cash flow (CN¥28.65 Million) in capital expenditures (CN¥286.36 Million). See ChengDa Pharmaceuticals Co. Ltd. net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ChengDa Pharmaceuticals Co. Ltd. Capital Reinvestment Ratio (2019–2024)
This chart tracks ChengDa Pharmaceuticals Co. Ltd.'s Capital Reinvestment Ratio across 6 annual periods. Check cash flow reinvestment rate of ChengDa Pharmaceuticals Co. Ltd. to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for ChengDa Pharmaceuticals Co. Ltd. (2019–2024)
Year-by-year Capital Reinvestment Ratio for ChengDa Pharmaceuticals Co. Ltd. from 2019 to 2024. For live market cap and broader valuation context, see ChengDa Pharmaceuticals Co. Ltd. stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 10.00x | CN¥28.65 Million | CN¥286.36 Million | ▲ +754.6% |
| 2023 | 1.17x | CN¥192.07 Million | CN¥224.67 Million | ▼ -72.9% |
| 2022 | 4.32x | CN¥47.67 Million | CN¥205.69 Million | ▲ +158.7% |
| 2021 | 1.67x | CN¥83.14 Million | CN¥138.70 Million | ▲ +237.2% |
| 2020 | 0.49x | CN¥128.97 Million | CN¥63.81 Million | ▼ -34.6% |
| 2019 | 0.76x | CN¥67.52 Million | CN¥51.06 Million | — |